GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Celgene Corporation (CELG) [hlAlert]

Rating:
Equal Weight
CELG
up 214.51 %

Celgene Corporation (CELG) rated Equal Weight with price target $130 by Barclays

Posted on: Wednesday,  Jul 15, 2015  4:25 PM ET by Barclays

Barclays rated Equal Weight Celgene Corporation (NASDAQ: CELG) on 07/15/2015. Previously Barclays rated Overweight Celgene Corporation (NASDAQ: CELG) on 04/02/2012.,
when the stock price was $39.12. Since then, Celgene Corporation has gained 214.52% as of 01/14/2016's recent price of $123.04.
If you would have followed the previous Barclays's recommendation on CELG, you would have gained 214.51% of your investment in 1382 days.

Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.

Barclays
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/15/2015 4:25 PM Buy
None
132.10 130.00
as of 8/27/2015
1 Week down  -4.32 %
1 Month up  2.24 %
3 Months up  6.91 %
1 YTD up  45.63 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/26/2013 1:25 PM Buy
None
71.41 79.00
4/26/2013 1:25 PM Buy
None
59.82 66.00
2/12/2013 3:25 PM Buy
None
49.52 55.50
1/25/2013 2:25 PM Buy
None
49.80 51.00
1/8/2013 2:25 PM Buy
None
45.40 47.00
6/22/2012 3:25 PM Buy
None
30.56 37.00
4/2/2012 1:25 PM Buy
None
39.12 43.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy